0001209191-17-037368.txt : 20170602
0001209191-17-037368.hdr.sgml : 20170602
20170602172313
ACCESSION NUMBER: 0001209191-17-037368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JACOBS JOEY A
CENTRAL INDEX KEY: 0001243878
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 17889099
MAIL ADDRESS:
STREET 1: 830 CRESCENT CENTER DRIVE
STREET 2: SUITE 610
CITY: FRANKLIN
STATE: TN
ZIP: 37067
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-31
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001243878
JACOBS JOEY A
2525 WEST END AVENUE
SUITE 950
NASHVILLE
TN
37203
1
0
0
0
Common Stock
2017-05-31
4
A
0
4000
6.53
A
61000
D
Restricted stock award will vest 100% on May 19, 2018.
Joey A. Jacobs by /s/ Michael Bonner as attorney-in-fact
2017-06-02